Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium.
Christophe J DuboisTom AdriaenssensLieven AnnemansJohan BosmansBritt CallebautPascal CandolfiKristoff CornelisAlexis DelbaereMichelle GreenJoelle KeferPatrizio LancellottiMichael RosseelJudith ShoreJan Van Der HeydenSebastian VermeerschEric WyffelsPublished in: Acta cardiologica (2023)
TAVI with SAPIEN 3 may offer a meaningful alternative intervention to SAVR in Belgian low-risk patients with sSAS, showing both clinical benefits and cost savings associated with post-procedure patient management.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- ejection fraction
- transcatheter aortic valve replacement
- aortic valve
- left ventricular
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- coronary artery disease
- newly diagnosed
- case report
- heart failure
- prognostic factors
- patient reported outcomes
- early onset
- peritoneal dialysis
- data analysis